I hope their trial is successful. Their investors
Post# of 148163
As per Patterson GM-CSF overexpression was found only in 20% of the patients he analyzed.
In any case, we need as many drugs a possible and GN-CSF would be a complementary drug to LL. Too bad they are in "bad company" with GILD